As Congress moves forward with its health agenda, the Endocrine Society has a number of priorities for diabetes prevention, treatment, and research legislation under consideration. These priorities include funding for the National Diabetes Prevention Program (NDPP), renewal of the Special Diabetes Program (SDP), and Medicare coverage for continuous glucose monitoring (CGM).
You may also like
August 2024 Endocrine Society Advocacy Update
Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…
Endocrine Society Continues Global EDC Advocacy; EU Election Results Leaves Outcomes for EDC Legislation Uncertain
On June 17, the Endocrine Society joined delegations from dozens of countries gathered in Geneva, Switzerland, for the third session of an ad hoc open-ended working group (OEWG) convened under the United Nations Environment Programme (UNEP) to develop proposals to establish a new science policy panel charged with helping to inform governments, companies, farmers and…
Loading ...